Search by Drug Name, NDC or Jcode
Internal Navigation
HCPCS Details
HCPC | J0897 |
Short Description | Denosumab injection |
Long Description | Injection, denosumab, 1 mg |
Pricing indicator | 51 |
Coverage code | C |
ASC payment group code | YY |
BETOS2 code | O1E |
Action code | N |
Type of service | 1 |
Effective date | 2012-01-01 |
Date Added | 2012-01-01 |
HCPCS/NDC Cross-Walk
NDC | HCPC | Description | Drug Name | Labeler Name | HCPCS Dosage | PKG Size | PKG QTY | Bill Units | Bill Units PKG |
---|---|---|---|---|---|---|---|---|---|
55513071001 | J0897 | Denosumab injection | Prolia | AMGEN USA, INC. | 1 MG | 1 | 1 | 60 | 60 |
55513073001 | J0897 | Denosumab injection | XGEVA | AMGEN USA, INC. | 1 MG | 1 | 1 | 120 | 120 |
HCPCS Billing Calculator
Dosage given to patient (per dose) | |
---|---|
HCPCS Dosage | 1 MG |
HCPCS/CPT Billing Units | 1 |
Total doses ordered | |
Billing Units | 1 |
Drug Details
-
Denosumab injection (Prolia) is used
-
to treat osteoporosis (a condition in which the bones become thin and weak and break easily) in women who have undergone menopause (''change of life;'' end of menstrual periods) who have an increased risk for fractures (broken bones) or who cannot take or did not respond to other medication treatments for osteoporosis.
-
to treat men who have an increased risk for fractures (broken bones) or who cannot take or did not respond to other medication treatments for osteoporosis.
-
treat osteoporosis that is caused by corticosteroid medications in men and women who will be taking corticosteroid medications for at least 6 months and have an increased risk for fractures or who cannot take or did not respond to other medication treatments for osteoporosis.
-
to treat bone loss in men who are being treated for prostate cancer with certain medications that cause bone loss,
-
to treat bone loss in women with breast cancer who are receiving certain medications that increase their risk for fractures.
-
-
Denosumab injection (Xgeva) is used
-
to reduce the risk of fractures in people who have multiple myeloma (cancer that begins in the plasma cells and causes bone damage), and in people who have certain types of cancer that began in another part of the body but has spread to the bones.
-
in adults and some adolescents to treat giant cell tumor of bone (GCTB; a type of bone tumor) that cannot be treated with surgery.
-
to treat high calcium levels that are caused by cancer in people who did not respond to other medications.
-